DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Hézode C, Lebray P, De Ledinghen V. et al.
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.
Liver Int 2017;
37: 1314-1324
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.